Biotech News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
BiotechNewsA Systematic Review and Meta-Analysis of the Auditory Steady-State Response in Schizophrenia, Bipolar Disorder, and Autism Spectrum Disorder
A Systematic Review and Meta-Analysis of the Auditory Steady-State Response in Schizophrenia, Bipolar Disorder, and Autism Spectrum Disorder
BioTech

A Systematic Review and Meta-Analysis of the Auditory Steady-State Response in Schizophrenia, Bipolar Disorder, and Autism Spectrum Disorder

•February 3, 2026
0
Nature (Biotechnology)
Nature (Biotechnology)•Feb 3, 2026

Why It Matters

ASSR deficits provide a neurophysiological window into circuit dysfunctions common to major psychiatric conditions, informing diagnosis and therapeutic development.

Key Takeaways

  • •40 Hz ASSR consistently reduced in schizophrenia
  • •Bipolar disorder shows moderate ASSR attenuation
  • •Autism spectrum disorder exhibits variable ASSR deficits
  • •ASSR deficits reflect excitation‑inhibition imbalance
  • •Potential biomarker for early detection across disorders

Pulse Analysis

The auditory steady‑state response, especially at the 40 Hz gamma frequency, has emerged as a sensitive probe of cortical synchrony. Recent meta‑analytic evidence consolidates decades of EEG and MEG research, showing that patients with schizophrenia exhibit the most pronounced attenuation of ASSR amplitude and phase‑locking. This reduction aligns with post‑mortem findings of impaired parvalbumin‑positive interneurons and disrupted GABAergic signaling, underscoring a core excitation‑inhibition imbalance that drives psychotic symptomatology. By quantifying these oscillatory deficits, clinicians gain an objective metric that complements traditional symptom scales.

In bipolar disorder, the ASSR signal is also compromised, though effect sizes are smaller and more variable across mood states and medication regimens. Studies indicate that manic or depressive episodes may modulate gamma‑band responsiveness, suggesting that ASSR could serve as a state‑dependent marker for treatment response. Moreover, the overlap of ASSR abnormalities between schizophrenia and bipolar disorder hints at shared neurobiological pathways, reinforcing the utility of cross‑diagnostic biomarkers in precision psychiatry.

Autism spectrum disorder presents a more heterogeneous ASSR profile, with some cohorts showing marked gamma‑band reductions while others report near‑normal responses. This variability likely reflects the disorder’s phenotypic diversity and differing developmental trajectories of cortical circuitry. Nonetheless, the consistent association of ASSR deficits with sensory processing challenges and social communication impairments positions the measure as a valuable tool for early identification. As research advances, integrating ASSR metrics with genetic, imaging, and behavioral data could accelerate the development of targeted interventions across the psychosis‑autism spectrum.

A systematic review and meta-analysis of the auditory steady-state response in schizophrenia, bipolar disorder, and autism spectrum disorder

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...